Hamburg “Guardedly Optimistic” On FDA 2012 Budget; OMB Plans 2013 Cuts
This article was originally published in The Rose Sheet
Executive Summary
FDA Commissioner Margaret Hamburg is "guardedly optimistic" the agency will retain its current funding level in fiscal 2012, but FDA and other agencies expect 5% lower budgets for the following year.
You may also be interested in...
House Cuts WIC Funding In Appropriations Bill
The House passes a fiscal 2012 appropriations bill with significant cuts to a program that provides infant formula for low-income women.
Bayer Relates Feeling ‘Sexy’ To Quick Relief For Allergies In Astepro Allergy Ad Campaign
Campaign featuring actress Meghann Fahy says "allergy sufferers can relieve their allergy symptoms and be more spontaneous in their romantic pursuits.” Ads launch two months after FDA granted tentative approval for two ANDAs for generic equivalents, indicating approval could come pending resolution of patent litigation.
US Infant Formula Supply Chain Strategy Delivered
FDA immediate actions include ensuring providers know they’re required to develop redundancy risk management plans, enhancing inspections of manufacturers, including by expanding and improving training for investigators, and expediting reviews of premarket submissions for new products.